UnknownNCT06657430
A Study on the Preference of Risperidone Dosage Forms
Observational studyAges 18+ChinaSchizophrenia
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- ShanghaiSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 19, 2024
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 1,000
- Sponsor
- Shanghai Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- Over 18 Years
- Official registry ID
- NCT06657430
- Official title
Show the full official title
A Study on the Preference of Risperidone Dosage Forms
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Shanghai
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.
Who can participate?
Listed age limits: from 18 years.
